Works by Witzig, Thomas E.

Results: 201

DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01145-0
By:
- Hopper, Melissa A.;
- Dropik, Abigail R.;
- Walker, Janek S.;
- Novak, Joseph P.;
- Laverty, Miranda S.;
- Manske, Michelle K.;
- Wu, Xiaosheng;
- Wenzl, Kerstin;
- Krull, Jordan E.;
- Sarangi, Vivekananda;
- Maurer, Matthew J.;
- Yang, Zhi-Zhang;
- Del Busso, Miles D.;
- Habermann, Thomas M.;
- Link, Brian K.;
- Rimsza, Lisa M.;
- Witzig, Thomas E.;
- Ansell, Stephen M.;
- Cerhan, James R.;
- Jevremovic, Dragan
Publication type:
Article
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00942-3
By:
- Bock, Allison M.;
- Gile, Jennifer J.;
- Larson, Melissa C.;
- Poonsombudlert, Kittika;
- Tawfiq, Reema K.;
- Maliske, Seth;
- Maurer, Matthew J.;
- Kabat, Brian F.;
- Paludo, Jonas;
- Inwards, David J.;
- Ayyappan, Sabarish;
- Link, Brian K.;
- Ansell, Stephen M.;
- Habermann, Thomas M.;
- Witzig, Thomas E.;
- Nowakowski, Grzegorz S.;
- Cerhan, James R.;
- Farooq, Umar;
- Wang, Yucai
Publication type:
Article
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00847-1
By:
- Correia, Cristina;
- Maurer, Matthew J.;
- McDonough, Samantha J.;
- Schneider, Paula A.;
- Ross, Paige E.;
- Novak, Anne J.;
- Feldman, Andrew L.;
- Cerhan, James R.;
- Slager, Susan L.;
- Witzig, Thomas E.;
- Eckloff, Bruce W.;
- Li, Hu;
- Nowakowski, Grzegorz S.;
- Kaufmann, Scott H.
Publication type:
Article
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00847-1
By:
- Correia, Cristina;
- Maurer, Matthew J.;
- McDonough, Samantha J.;
- Schneider, Paula A.;
- Ross, Paige E.;
- Novak, Anne J.;
- Feldman, Andrew L.;
- Cerhan, James R.;
- Slager, Susan L.;
- Witzig, Thomas E.;
- Eckloff, Bruce W.;
- Li, Hu;
- Nowakowski, Grzegorz S.;
- Kaufmann, Scott H.
Publication type:
Article
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x
By:
- Desai, Sanjal H.;
- Pederson, Levi;
- LaPlant, Betsy;
- Mwangi, Raphael;
- Maurer, Matthew;
- Young, Jason R.;
- Macon, William R.;
- King, Rebecca L.;
- Wang, Yucai;
- Cerhan, James R.;
- Feldman, Andrew;
- Inwards, David J.;
- Micallef, Ivana;
- Johnston, Patrick;
- Porrata, Luis F.;
- Ansell, Stephen M.;
- Habermann, Thomas M.;
- Witzig, Thomas E.;
- Nowakowski, Grzegorz S.
Publication type:
Article
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-021-00598-x
By:
- Wang, Yucai;
- Zhou, Shouhao;
- Qi, Xinyue;
- Yang, Fang;
- Maurer, Matthew J.;
- Habermann, Thomas M.;
- Witzig, Thomas E.;
- Wang, Michael L.;
- Nowakowski, Grzegorz S.
Publication type:
Article
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
By:
- Desai, Sanjal H.;
- LaPlant, Betsy;
- Macon, William R.;
- King, Rebecca L.;
- Wang, Yucai;
- Inwards, David J.;
- Micallef, Ivana;
- Johnston, Patrick B.;
- Porrata, Luis F.;
- Ansell, Stephen M.;
- Habermann, Thomas M.;
- Witzig, Thomas E.;
- Nowakowski, Grzegorz S.
Publication type:
Article
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00525-0
By:
- Arushi Khurana;
- Mwangi, Raphael;
- Ansell, Stephen M.;
- Habermann, Thomas M.;
- Cerhan, James R.;
- Strouse, Christopher;
- Link, Brian K.;
- Wang, Yucai;
- King, Rebecca L.;
- Macon, William R.;
- Villasboas, J. C.;
- Witzig, Thomas E.;
- Maurer, Matthew J.;
- Nowakowski, Grzegorz S.
Publication type:
Article
Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00452-0
By:
- Gile, Jennifer J.;
- Lopez, Camden L.;
- Ruan, Gordon J.;
- Hathcock, Matthew A.;
- Abeykoon, Jithma P.;
- Heimgartner, Joy R.;
- Baumann, Nikola A.;
- McMahon, M. Molly;
- Micallef, Ivana N.;
- Johnston, Patrick B.;
- Bisneto, Jose C. Villasboas;
- Porrata, Luis F.;
- Paludo, Jonas;
- Ansell, Stephen M.;
- Hogan, William J.;
- Witzig, Thomas E.
Publication type:
Article
JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis.
Published in:
2021
By:
- Le, Kang;
- Wellik, Linda E.;
- Maurer, Matthew J.;
- McPhail, Ellen D.;
- Witzig, Thomas E.;
- Gupta, Mamta
Publication type:
Letter
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00394-z
By:
- Castellino, Alessia;
- Tun, Aung M.;
- Wang, Yucai;
- Habermann, Thomas M.;
- King, Rebecca L.;
- Ristow, Kay M.;
- Cerhan, James R.;
- Inwards, David J.;
- Paludo, Jonas;
- Ansell, Stephen M.;
- Witzig, Thomas E.;
- Nowakowski, Grzegorz S.
Publication type:
Article
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.
Published in:
Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0233-5
By:
- Wang, Yucai;
- Wenzl, Kerstin;
- Manske, Michelle K.;
- Asmann, Yan W.;
- Sarangi, Vivekananda;
- Greipp, Patricia T.;
- Krull, Jordan E.;
- Hartert, Keenan;
- He, Rong;
- Feldman, Andrew L.;
- Maurer, Matthew J.;
- Slager, Susan L.;
- Nowakowski, Grzegorz S.;
- Habermann, Thomas M.;
- Witzig, Thomas E.;
- Link, Brian K.;
- Ansell, Stephen M.;
- Cerhan, James R.;
- Novak, Anne J.
Publication type:
Article
Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma.
Published in:
Blood Cancer Journal, 2019, v. 9, n. 6, p. N.PAG, doi. 10.1038/s41408-019-0208-6
By:
- Nowakowski, Grzegorz S.;
- Feldman, Tatyana;
- Rimsza, Lisa M.;
- Westin, Jason R.;
- Witzig, Thomas E.;
- Zinzani, Pier Luigi
Publication type:
Article
Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability.
Published in:
International Journal of Cancer, 2007, v. 120, n. 6, p. 1232, doi. 10.1002/ijc.22429
By:
- Sinicrope, Frank A.;
- Rego, Rafaela L.;
- Garrity-Park, Megan M.;
- Foster, Nathan R.;
- Sargent, Daniel J.;
- Goldberg, Richard M.;
- Wiesenfeld, Myron;
- Witzig, Thomas E.;
- Thibodeau, Stephen N.;
- Burgart, Lawrence J.
Publication type:
Article
Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-hodgkin lymphoma.
Published in:
International Journal of Cancer, 2003, v. 106, n. 5, p. 784, doi. 10.1002/ijc.11311
By:
- James R. Cerhan;
- Kristin E. Anderson;
- Carol A. Janney;
- Celine M. Vachon;
- Thomas E. Witzig;
- Thomas M. Habermann
Publication type:
Article
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 259, doi. 10.1016/j.clml.2023.01.010
By:
- Moustafa, Muhamad Alhaj;
- Borah, Bijan J.;
- Moriarty, James P.;
- Dholakia, Ruchita;
- Jiang, Liuyan;
- Li, Ke;
- Witzig, Thomas E.;
- Hoppe, Bradford S.;
- Peterson, Jennifer;
- Cerhan, James R.;
- Tun, Han W
Publication type:
Article
Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. 618, doi. 10.1016/j.clml.2022.03.004
By:
- Moustafa, Muhamad Alhaj;
- Peterson, Jennifer;
- Hoppe, Bradford S.;
- Jiang, Jennifer;
- Wiseman, Gregory A.;
- Witzig, Thomas E.;
- Tun, Han W.
Publication type:
Article
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e815, doi. 10.1016/j.clml.2022.04.009
By:
- Kuhlman, Justin J.;
- Moustafa, Muhamad Alhaj;
- Jiang, Liuyan;
- Iqbal, Madiha;
- Seegobin, Karan;
- Wolcott, Zoe;
- Ayala, Ernesto;
- Ansell, Steve;
- Rosenthal, Allison;
- Paludo, Jonas;
- Micallef, Ivana;
- Johnston, Patrick;
- Inwards, David;
- Habermann, Thomas;
- Kharfan-Dabaja, Mohamed;
- Witzig, Thomas E.;
- Nowakowski, Grzegorz S.;
- Tun, Han W.
Publication type:
Article
MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S408, doi. 10.1016/S2152-2650(21)01919-4
By:
- Yucai Wang;
- Castellino, Alessia;
- Larson, Melissa C.;
- Maurer, Matthew J.;
- Link, Brian K.;
- Farooq, Umar;
- Inwards, David J.;
- Ansell, Stephen M.;
- Witzig, Thomas E.;
- Habermann, Thomas M.;
- Cerhan, James R.;
- Nowakowski, Grzegorz S.
Publication type:
Article
Poster: MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S246, doi. 10.1016/S2152-2650(21)01551-2
By:
- Wang, Yucai;
- Castellino, Alessia;
- Larson, Melissa C.;
- Maurer, Matthew J.;
- Link, Brian K.;
- Farooq, Umar;
- Inwards, David J.;
- Ansell, Stephen M.;
- Witzig, Thomas E.;
- Habermann, Thomas M.;
- Cerhan, James R.;
- Nowakowski, Grzegorz S.
Publication type:
Article
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.
Published in:
2018
By:
- Padrnos, Leslie;
- Ernst, Brenda;
- Dueck, Amylou C.;
- Kosiorek, Heidi E.;
- Ginos, Brenda F.;
- Toro, Angela;
- Johnston, Patrick B.;
- Habermann, Thomas M.;
- Leis, Jose F.;
- Mikhael, Joseph R.;
- Nowakowski, Grzegorz S.;
- Colgan, Joseph;
- Porrata, Luis;
- Ansell, Stephen M.;
- Witzig, Thomas E.;
- Reeder, Craig
Publication type:
journal article
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
Published in:
British Journal of Haematology, 2006, v. 134, n. 6, p. 596, doi. 10.1111/j.1365-2141.2006.06232.x
By:
- Siddiqui, Mustaqeem;
- Ristow, Kay;
- Markovic, Svetomir N.;
- Witzig, Thomas E.;
- Habermann, Thomas M.;
- Colgan, Joseph P.;
- Inwards, David J.;
- White, William L.;
- Ansell, Stephen M.;
- Micallef, Ivana N.;
- Johnston, Patrick B.;
- Call, Timothy G.;
- Porrata, Luis F.
Publication type:
Article
Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia.
Published in:
British Journal of Haematology, 2006, v. 133, n. 2, p. 158, doi. 10.1111/j.1365-2141.2006.06003.x
By:
- Ghobrial, Irene M.;
- Fonseca, Rafael;
- Gertz, Morie A.;
- Plevak, Matthew F.;
- Larson, Dirk R.;
- Therneau, Terry M.;
- Wolf, Robert C.;
- Hoffmann, Randi J.;
- Lust, John A.;
- Witzig, Thomas E.;
- Lacy, Martha Q.;
- Dispenzieri, Angela;
- Rajkumar, S. Vincent;
- Zeldenrust, Stephen R.;
- Greipp, Philip R.;
- Kyle, Robert A.
Publication type:
Article
SHORT REPORT Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma.
Published in:
British Journal of Haematology, 2003, v. 123, n. 2, p. 305, doi. 10.1046/j.1365-2141.2003.04605.x
By:
- Thompson, Michael A.;
- Witzig, Thomas E.;
- Kumar, Shaji;
- Timm, Michael M.;
- Haug, Jessica;
- Fonseca, Rafael;
- Greipp, Philip R.;
- Lust, John A.;
- Rajkumar, S. Vincent
Publication type:
Article
Bone marrow angiogenesis and circulating plasma cells in multiple myeloma.
Published in:
British Journal of Haematology, 2003, v. 122, n. 2, p. 272, doi. 10.1046/j.1365-2141.2003.04428.x
By:
- Kumar, Shaji;
- Witzig, Thomas E.;
- Greipp, Philip R.;
- Rajkumar, S. Vincent
Publication type:
Article
Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2003, v. 121, n. 2, p. 287, doi. 10.1046/j.1365-2141.2003.04265.x
By:
- Dewald, Gordon W.;
- Brockman, Stephanie R.;
- Paternoster, Sarah F.;
- Bone, Nancy D.;
- O'Fallon, Judith R.;
- Allmer, Cristine;
- James, Charles D.;
- Jelinek, Diane F.;
- Tschumper, Renee C.;
- Hanson, Curtis A.;
- Pruthi, Rajiv K.;
- Witzig, Thomas E.;
- Call, Timothy G.;
- Kay, Neil E.
Publication type:
Article
Bone marrow angiogenesis in multiple myeloma: effect of therapy.
Published in:
British Journal of Haematology, 2002, v. 119, n. 3, p. 665, doi. 10.1046/j.1365-2141.2002.03871.x
By:
- Kumar, Shaji;
- Fonseca, Rafael;
- Dispenzieri, Angela;
- Lacy, Martha Q.;
- Lust, John A.;
- Witzig, Thomas E.;
- Gertz, Morie A.;
- Kyle, Robert A.;
- Greipp, Philip R.;
- Rajkumar, S. Vincent
Publication type:
Article
Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2001, v. 115, n. 4, p. 854, doi. 10.1046/j.1365-2141.2001.03149.x
By:
- Jelinek, Diane F.;
- Tschumper, Renee C.;
- Geyer, Susan M.;
- Bone, Nancy D.;
- Dewald, Gordon W.;
- Hanson, Curtis A.;
- Stenson, Mary J.;
- Witzig, Thomas E.;
- Tefferi, Ayalew;
- Kay, Neil E.
Publication type:
Article
Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil.
Published in:
British Journal of Haematology, 2000, v. 108, n. 4, p. 737, doi. 10.1046/j.1365-2141.2000.01918.x
By:
- Kyle, Robert A.;
- Greipp, Philip R.;
- Gertz, Morie A.;
- Witzig, Thomas E.;
- Lust, John A.;
- Lacy, Martha Q.;
- Therneau, Terry M.
Publication type:
Article
Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases.
Published in:
British Journal of Haematology, 1998, v. 101, n. 2, p. 296, doi. 10.1046/j.1365-2141.1998.00700.x
By:
- Fonseca, Rafael;
- Witzig, Thomas E.;
- Gertz, Morie A.;
- Kyle, Robert A.;
- Hoyer, James D.;
- Jalal, Syed M.;
- Greipp, Philip R.;
- Greipp
Publication type:
Article
Detection of monoclonal plasma cells in the peripheral blood of patients with primary amyloidosis.
Published in:
British Journal of Haematology, 1998, v. 100, n. 2, p. 326, doi. 10.1046/j.1365-2141.1998.00583.x
By:
- MCElroy, JR, Edwin A.;
- Witzig, Thomas E.;
- Gertz, Morie A.;
- Greipp, Philip R.;
- Kyle, Robert A.
Publication type:
Article
Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity?
Published in:
British Journal of Haematology, 1995, v. 90, n. 2, p. 459, doi. 10.1111/j.1365-2141.1995.tb05175.x
By:
- MATHEW, PAUL;
- AHMANN, GREGORY J.;
- WITZIG, THOMAS E.;
- ROCHE, PATRICK C.;
- KYLE, ROBERT A.;
- GREIPP, PHILIP R.
Publication type:
Article
Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma.
Published in:
British Journal of Haematology, 1995, v. 89, n. 3, p. 640, doi. 10.1111/j.1365-2141.1995.tb08378.x
By:
- Witzig, Thomas E.;
- Gertz, Morie A.;
- Pineda, Alvaro A.;
- Kyle, Robert A.;
- Greipp, Philip R.
Publication type:
Article
Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma.
Published in:
British Journal of Haematology, 1994, v. 87, n. 2, p. 266, doi. 10.1111/j.1365-2141.1994.tb04908.x
By:
- Witzig, Thomas E.;
- Kyle, Robert A.;
- O'Fallon, William M.;
- Greipp, Philip R.
Publication type:
Article
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.
Published in:
2018
By:
- Paludo, Jonas;
- Abeykoon, Jithma P.;
- Shreders, Amanda;
- Ansell, Stephen M.;
- Kumar, Shaji;
- Ailawadhi, Sikander;
- King, Rebecca L.;
- Koehler, Amber B.;
- Reeder, Craig B.;
- Buadi, Francis K.;
- Dispenzieri, Angela;
- Lacy, Martha Q.;
- Dingli, David;
- Witzig, Thomas E.;
- Go, Ronald S.;
- Gonsalves, Wilson I.;
- Kourelis, Taxiarchis;
- Warsame, Rahma;
- Leung, Nelson;
- Habermann, Thomas M.
Publication type:
journal article
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
Published in:
Annals of Hematology, 2011, v. 90, n. 1, p. 101, doi. 10.1007/s00277-010-1028-8
By:
- Siragusa, Sergio;
- Morice, William;
- Gertz, Morie A.;
- Kyle, Robert A.;
- Greipp, Philip R.;
- Lust, John A.;
- Witzig, Thomas E.;
- Lacy, Martha Q.;
- Zeldenrust, Steven R.;
- Rajkumar, S. Vincent;
- Russell, Stephen J.;
- Hayman, Suzanne R.;
- Buadi, Francis;
- Kumar, Shaji K.;
- Dingli, David;
- Dispenzieri, Angela
Publication type:
Article
Targeting apoptosis pathways in cancer therapy.
Published in:
2005
By:
- Ghobrial, Irene M.;
- Witzig, Thomas E.;
- Adjei, Alex A.
Publication type:
journal article
Recurrent acute inflammatory demyelinating polyradiculoneuropathy following R-CHOP treatment for non-Hodgkin lymphoma.
Published in:
2013
By:
- Liang, Jackson J.;
- Singh, Preet P.;
- Witzig, Thomas E.
Publication type:
Journal Article
Recurrent acute inflammatory demyelinating polyradiculoneuropathy following R-CHOP treatment for non-Hodgkin lymphoma.
Published in:
Baylor University Medical Center Proceedings, 2013, v. 26, n. 2, p. 156, doi. 10.1080/08998280.2013.11928942
By:
- Liang, Jackson J.;
- Singh, Preet P.;
- Witzig, Thomas E.
Publication type:
Article
Low Plasma Omega-3 Fatty Acid Levels May Predict Inferior Prognosis in Untreated Diffuse Large B-Cell Lymphoma: A New Modifiable Dietary Biomarker?
Published in:
Nutrition & Cancer, 2018, v. 70, n. 7, p. 1088, doi. 10.1080/01635581.2018.1502328
By:
- Thanarajasingam, Gita;
- Maurer, Matthew J.;
- Habermann, Thomas M.;
- Nowakowski, Grzegorz S.;
- Bennani, N. Nora;
- Thompson, Carrie A.;
- Cerhan, James R.;
- Witzig, Thomas E.
Publication type:
Article
The Effect of a Neutropenic Diet on Infection and Mortality Rates in Cancer Patients: A Meta-Analysis.
Published in:
Nutrition & Cancer, 2015, v. 67, n. 8, p. 1230, doi. 10.1080/01635581.2015.1082109
By:
- Sonbol, Mohamad Bassam;
- Firwana, Belal;
- Diab, Maria;
- Zarzour, Ahmad;
- Witzig, Thomas E.
Publication type:
Article
The Treatment of Recurrent/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) With Everolimus Results in Clinical Responses and Mobilization of CLL Cells Into the Circulation.
Published in:
Cancer (0008543X), 2010, v. 116, n. 9, p. 2201, doi. 10.1002/cncr.25005
By:
- Zent, Clive S.;
- LaPlant, Betsy R.;
- Johnston, Patrick B.;
- Call, Timothy G.;
- Habermann, Thomas M.;
- Micallef, Ivana N.;
- Witzig, Thomas E.
Publication type:
Article
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group.
Published in:
2008
By:
- Ansell, Stephen M.;
- Inwards, David J.;
- Rowland Jr, Kendrith M.;
- Flynn, Patrick J.;
- Morton, Roscoe F.;
- Moore Jr, Dennis F.;
- Kaufmann, Scott H.;
- Ghobrial, Irene;
- Kurtin, Paul J.;
- Maurer, Matthew;
- Alimer, Christine;
- Witzig, Thomas E.;
- Rowland, Kendrith M Jr;
- Moore, Dennis F Jr;
- Allmer, Christine
Publication type:
journal article
Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group.
Published in:
2008
By:
- Inwards, David J.;
- Fishkin, Paul A. S.;
- Hillman, David W.;
- Brown, David W.;
- Ansell, Stephen M.;
- Kurtin, Paul J.;
- Fonseca, Rafael;
- Morton, Roscoe F.;
- Veeder, Michael H.;
- Witzig, Thomas E.
Publication type:
journal article
Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan.
Published in:
2007
By:
- Witzig, Thomas E.;
- Molina, Arturo;
- Gordon, Leo I.;
- Emmanouilides, Christos;
- Schilder, Russell J.;
- Flinn, Ian W.;
- Darif, Mohamed;
- Macklis, Roger;
- Vo, Katie;
- Wiseman, Gregory A.
Publication type:
journal article
Safety and efficacy of external beam radiation therapy for non-Hodgkin lymphoma in patients with prior 90Y-ibritumomab tiuxetan radioimmunotherapy.
Published in:
2006
By:
- Justice, Terry E.;
- Martenson, James A.;
- Wiseman, Gregory A.;
- Witzig, Thomas E.
Publication type:
journal article
High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis.
Published in:
Cancer (0008543X), 2004, v. 100, n. 11, p. 2403
By:
- Irene M. Ghobrial;
- Francis Buadi;
- Robert J. Spinner;
- Joseph P. Colgan;
- Alexandra P. Wolanskyj;
- P. James Dyck;
- Thomas E. Witzig;
- Ivana N. Micallef;
- Brian Patrick O'Neill
Publication type:
Article
Radiation dosimetry results for zevalin radioimmunotherapy of rituximab-refractory non-hodgkin lymphoma.
Published in:
Cancer (0008543X), 2002, v. 94, n. S4, p. 1349, doi. 10.1002/cncr.10305
By:
- Wiseman, Gregory A.;
- Leigh, Bryan;
- Erwin, William D.;
- Lamonica, Dominick;
- Kornmehl, Ellen;
- Spies, Stewart M.;
- Silverman, Daniel H. S.;
- Witzig, Thomas E.;
- Sparks, Richard B.;
- White, Christine A.
Publication type:
Article
Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells.
Published in:
British Journal of Haematology, 2018, v. 183, n. 2, p. 196, doi. 10.1111/bjh.15515
By:
- Paulus, Aneel;
- Manna, Alak;
- Akhtar, Sharoon;
- Paulus, Shumail M.;
- Sharma, Mayank;
- Coignet, Marie V.;
- Jiang, Liuyan;
- Roy, Vivek;
- Witzig, Thomas E.;
- Ansell, Stephen M.;
- Allan, John;
- Furman, Richard;
- Aulakh, Sonikpreet;
- Manochakian, Rami;
- Ailawadhi, Sikander;
- Chanan‐Khan, Asher A.;
- Sher, Taimur
Publication type:
Article
Event‐free survival at 24 months captures central nervous system relapse of systemic diffuse large B‐cell lymphoma in the immunochemotherapy era.
Published in:
British Journal of Haematology, 2018, v. 183, n. 1, p. 149, doi. 10.1111/bjh.14922
By:
- Thanarajasingam, Gita;
- Maurer, Matthew J.;
- Farooq, Umar;
- Johnston, Patrick B.;
- Thompson, Carrie A.;
- Bennani, Nabila N.;
- Ansell, Stephen M.;
- Porrata, Luis F.;
- Macon, William R.;
- Syrbu, Sergei I.;
- Cerhan, James R.;
- Habermann, Thomas M.;
- Link, Brian K.;
- Witzig, Thomas E.;
- Nowakowski, Grzegorz S.
Publication type:
Article